Accessibility Menu
Advanced BioMedical Technologies logo

Advanced BioMedical Technologies(OTC) ABMT

Market Cap$50.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-99%
1 Year+400%
1 Month+0%
$0.00
+0%
+0.00Today
Advanced BioMedical Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-20
Advanced BioMedical Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-06-16
1 month+0%USD 0.002026-06-16
3 month+0%USD 0.002026-03-23
Year to date+25%USD 0.002025-12-18
1 year+400%USD 0.002025-07-07
3 year-98.59%USD 0.042023-07-18
5 year-99.28%USD 0.072021-07-21
Since inception-99.98%USD 3.002009-05-04

Advanced BioMedical Technologies Financials at a Glance

Market Cap

$50.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$400.13K

Net Income (TTM)

-$491.76K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.02 (Low)

Price

$0.00

Volume

1,770

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 31, 2021

ABMT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Advanced BioMedical Technologies

Advanced BioMedical Technologies Inc. is a development stage company focused on designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company specializes in polymer osteosynthesis devices for orthopedic trauma, sports-related medical treatment, cartilage repair, and reconstructive dental procedures.

Products and Services
  • Polymer osteosynthesis devices including surgical screws and binding wires
  • Medical devices for orthopedic trauma and cartilage repair
  • Reconstructive dental procedure solutions
Growth Outlook
  • Market demand for orthopedic devices is projected to grow significantly
  • Expansion into new medical applications is underway
  • Strategic partnerships may enhance product development capabilities
Financial Highlights
  • Recent quarterly revenue of -$4,939 indicates ongoing challenges
  • Trailing twelve months (TTM) gross profit margin stands at 81.88%
  • Current liabilities significantly exceed current assets, indicating liquidity concerns
Advanced BioMedical Technologies Inc. operates in the medical devices sector, focusing on innovative solutions for orthopedic and dental applications. Despite facing financial challenges, the company maintains a strong gross profit margin, suggesting potential for profitability with improved operational efficiency. The growth outlook remains positive, driven by increasing market demand and opportunities for expansion into new medical applications. However, liquidity issues highlighted by the current ratio indicate a need for careful financial management moving forward.
AI Generated • Jul 28, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hui Wang

Website

www.abtlafleur.com

Headquarters

New York, NY 10166, US

ABMT Financials

Key Financial Metrics (TTM)

Gross Margin

81.88%

Operating Margin

-66.38%

Net Income Margin

-190.22%

Return on Equity

6.32%

Return on Capital

N/A

Return on Assets

-130.27%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$50.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

100.00M

Volume

1.77K

Avg. Volume

81.774

Financials (TTM)

Gross Profit

$317.74K

Operating Income

-$149.36K

EBITDA

-$137.52K

Operating Cash Flow

-$626.35K

Capital Expenditure

$271.99

Free Cash Flow

-$626.08K

Cash & ST Invst.

$5.70K

Total Debt

$7.09M

Advanced BioMedical Technologies Performance Analysis

Advanced BioMedical Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-10-31USD 171,192N/A
20222022-10-31USD 270,99158.3%
Advanced BioMedical Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-10-3168613.3%
Q12022-01-31127.6%
Q22022-04-30-100.0%
Q32022-07-31-4742.2%
Advanced BioMedical Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-10-31USD -0.01N/A
20222022-10-31USD -0.01-29.8%
Advanced BioMedical Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42021-10-3114.3%
Q12022-01-31133.3%
Q22022-04-30-437.5%
Q32022-07-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

-$4.94K

-2843.9%

Gross Profit

-$7.29K

-5234.5%

Gross Margin

1.48%

N/A

Market Cap

$50.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.94K

N/A

Employees

17

N/A

Net Income

-$189.79K

+4.5%

EBITDA

-$103.96K

+5.8%

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Total Cash

$5.70K

-18.4%

Total Debt

$7.09M

+65435.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$239.93K

+27.1%

Long Term Debt

$0.00

N/A

Short Term Debt

$7.09M

+32667.8%

Return on Assets

-1.30%

N/A

Return on Invested Capital

2.27%

N/A

Free Cash Flow

-$170.31K

-105.4%

Operating Cash Flow

-$170.31K

-110.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTLFPetlife Pharmaceuticals, Inc.
$0.00+0.00%
HSMDHealthcare Solutions Management Group, Inc.
$0.00+0.00%
VRAYQViewRay, Inc.
$0.00+0.00%
WCUIWellness Center USA, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About ABMT

What is the current price of Advanced BioMedical Technologies?

Advanced BioMedical Technologies is trading at $0.00 per share.

What is the 52-week range for Advanced BioMedical Technologies?

Over the past 52 weeks, Advanced BioMedical Technologies has traded between $0.00 and $0.00.

How much debt does Advanced BioMedical Technologies have?

As of the most recent reporting period, Advanced BioMedical Technologies reported total debt of $6.81M.

How much cash does Advanced BioMedical Technologies have on hand?

Advanced BioMedical Technologies reported $4.85K in cash and cash equivalents in its most recent financial results.

What is Advanced BioMedical Technologies’s dividend yield?

Advanced BioMedical Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services